Investigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia

NCT06957808 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia Disorders

Interventions

DRUG: Diroximel fumarate (DRF)
DRUG: Placebo

Sponsor

King's College London

Collaborators

[object Object]
[object Object]